Category:

07 November 2022

BOARD OF DIRECTORS APPROVES INTERIM MANAGEMENT REPORT AS AT 30 SEPTEMBER 2022

15 September 2022

PHARMANUTRA S.P.A. LAUNCHES NEW PRODUCTS CETILAR® ORO AND APPORTAL® VITAL

14 September 2022

HALF-YEAR FINANCIAL REPORT AS OF 30 JUNE 2022

05 September 2022

THE BOD APPROVES THE FIRST HALF FINANCIAL REPORT AS AT 30/06/2022 AND THE GROUP’S FIRST SUSTAINABILITY REPORT

04 August 2022

BUY-BACK REPORT JULY 2022

26 July 2022

PHARMANUTRA S.P.A.: FIRST ACQUISITION CLOSING OF AKERN S.R.L. FINALISED

06 July 2022

BUY-BACK REPORT JUNE 2022

17 June 2022

GOLDEN POWER NOTIFICATION FILED IN CONNECTION WITH THE ACQUISITION OF 100% OF AKERN S.R.L.

15 June 2022

SIGNING OF THE AGREEMENT FOR THE ACQUISITION OF 100% OF AKERN S.R.L.

08 June 2022

BUY-BACK REPORT MAY 2022

27 May 2022

PUBLICATION OF THE SHAREHOLDERS’ MEETINGS MINUTES HELD ON 27/04/2022

16 May 2022

PHARMANUTRA S.P.A.: INITIATION OF SHARE BUY-BACK PROGRAM

12 May 2022

INTERIM FINANCIAL REPORT AS OF 31 MARCH 2022 NOW AVAILABLE

09 May 2022

PHARMANUTRA S.P.A.: INTERIM REPORT AS AT 31 MARCH 2022

02 May 2022

SYNTHETIC REPORT ON VOTING RESULTS OF THE SHAREHOLDERS’ MEETINGS 27/04/2022

27 April 2022

RESOLUTIONS OF THE SHAREHOLDERS’ MEETING OF 27/04/2022

11 April 2022

BUY-BACK REPORT MARCH 2022

31 March 2022

NOTICE OF PUBLICATIONOF THE 2021 ANNUAL FINANCIAL REPORT

18 March 2022

PHARMANUTRA S.P.A.: FILING OF DOCUMENTS FOR THE SHAREHOLDERS’ MEETING

18 March 2022

PHARMANUTRA S.P.A.: THE BOARD APPROVES THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT 31 DECEMBER 2021

08 March 2022

BUY-BACK REPORT FEBRUARY 2022

< 1 … 3 4 5 … 12 >